Endocrine Today Current Issue
The following articles appeared in the print edition of Endocrine Today.
Table of Contents
- Experts call for improved FDA Risk Evaluation and Mitigation Strategy program
-
- AACE declines endorsement of recent AHA/ACC/TOS guidelines
- Breast-feeding may provide infants with adequate iodine supplementation
- Combination angiotensin inhibition increased hyperkalemia, acute kidney injury in diabetic neuropathy
- EHR data reveal low rate of follow-up, treatment for prediabetes
- Policymakers exhibit knowledge gap on obesity epidemic
- Race, genetics explained variations in 25-hydroxyvitamin D
- Studies offer insight into rare adrenal disorder
- Future of endocrinology: The Affordable Care Act and ACOs Alan J. Garber, MD, PhD, MACE
-
- FDA approves dapagliflozin for type 2 diabetes
- Adrenal mass with macroscopic fat found during routine imaging Stephanie L. Lee, MD, PhD, ECNU
- Bilateral oophorectomy may increase risk for diabetes
- Common diabetes drugs may lower cancer risk for women
- Composite measures predicted bariatric surgery performance better than other methods
- ELITE: Lower postmenopausal estrogen levels unrelated to cognition, mood
- Gender affects heart’s response to diabetes therapy
- GnRH stimulation test not predictive of precocious puberty in girls with premature thelarche
-
- Interactive fitness game improved glycemic control in type 2 diabetes
- Levothyroxine could suppress TSH in subclinical thyroid disease
- Metformin modestly effective, not superior, in childhood obesity
- Significant weight loss observed 3 years after bariatric surgery
- Is SMBG in type 2 diabetes worth it? James R. Taylor, PharmD, CDE